AMAT vs DHR: Which Is the Better Buy?
Side-by-side comparison of Applied Materials, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Applied Materials, Inc. · Technology
$617.11
-45.0% upside to fair value
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMAT |
DHR |
| Current Price |
$617.11 |
$177.17 |
| Fair Value Estimate |
$339.41 |
$192.90 |
| Upside to Fair Value |
-45.0%
|
+8.9%
|
| Market Cap |
$490.0B |
$125.4B |
| Forward P/E |
57.7x
|
34.1x
|
| EV / EBITDA |
44.0x
|
20.8x
|
| Price / Sales |
16.9x
|
5.1x
|
| Price / FCF |
82.1x
|
23.7x
|
| Revenue Growth YoY |
+11.4%
|
+3.7%
|
| Gross Margin |
49.0%
|
60.7%
|
| Operating Margin |
29.5%
|
21.0%
|
| Return on Equity |
39.8%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.22%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Applied Materials, Inc. is a leading semiconductor equipment manufacturer specializing in wafer fabrication equipment and services, with a strong competitive moat in deposition, etch, implant, and services segments. Led by CEO Gary Dickerson with over 12 years at the helm, the company has demonstrated durable earnings growth and a robust patent portfolio. Despite solid revenue growth of 11.4% and…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
AMAT |
DHR |
| Zone Low |
$254.56 |
$144.68 |
| Zone High |
$288.50 |
$163.97 |
| In Buy Zone? |
No
|
No
|